
COMPOSITION
Each delayed-release capsule formulation contains enteric-coated pellets of Duloxetine hydrochloride
equivalent to 60 mg of Duloxetine that are designed to prevent degradation of the drug in the acidic
environment of the stomach.
INDICATIONS
Duloxetine is indicated for the treatment of depression.
Duloxetine is indicated for the treatment of diabetic neuropathic pain (DPNP).
Duloxetine is indicated for the treatment of generalized anxiety disorde...
More